PACB,DNA Stock Price and Quote

Dollar change -0.02
Percentage change -1.44	%

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB SCHA VTWO VHT

Index	RUT	P/E	-	EPS (ttm)	-2.77	Insider Own	11.97%	Shs Outstand	300.04M	Perf Week	-6.80%
Market Cap	411.12M	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-1.13%	Shs Float	264.16M	Perf Month	5.38%
Enterprise Value	766.43M	PEG	-	EPS next Q	-0.17	Inst Own	65.79%	Short Float	17.93%	Perf Quarter	14.17%
Income	-656.55M	P/S	2.70	EPS this Y	14.96%	Inst Trans	-12.61%	Short Ratio	5.20	Perf Half Y	-21.49%
Sales	152.36M	P/B	4.49	EPS next Y	45.53%	ROA	-51.89%	Short Interest	47.37M	Perf YTD	-25.14%
Book/sh	0.31	P/C	1.20	EPS next 5Y	27.35%	ROE	-177.29%	52W High	2.72 -49.63%	Perf Year	-37.01%
Cash/sh	1.15	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-83.28%	52W Low	0.85 60.97%	Perf 3Y	-73.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-230.61%	Volatility	8.45% 8.07%	Perf 5Y	-63.85%
Dividend TTM	-	EV/Sales	5.03	EPS Y/Y TTM	-100.40%	Oper. Margin	-401.03%	ATR (14)	0.11	Perf 10Y	-74.05%
Dividend Ex-Date	-	Quick Ratio	5.87	Sales Y/Y TTM	-23.99%	Profit Margin	-430.93%	RSI (14)	51.43	Recom	2.31
Dividend Gr. 3/5Y	- -	Current Ratio	6.68	EPS Q/Q	-394.93%	SMA20	-0.90%	Beta	2.17	Target Price	1.96
Payout	-	Debt/Eq	7.63	Sales Q/Q	-4.27%	SMA50	13.15%	Rel Volume	0.48	Prev Close	1.39
Employees	575	LT Debt/Eq	7.60	Earnings	May 08 AMC	SMA200	-11.38%	Avg Volume	9.11M	Price	1.37
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	-649.61% 4.83%	Trades		Volume	4,374,752	Change	-1.44%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Jul-17-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks) -6.71%
Jul-10-25 06:15PM	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Jul-09-25 11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jul-08-25 12:00PM	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
06:15PM	Loading…
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM	The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-10-25 06:41AM	PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM	Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
Jun-02-25 10:00AM	Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
May-28-25 09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) +20.85%
10:46AM	Loading…
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
May-22-25 09:05AM	PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene (GlobeNewswire)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
10:56AM	PacBio Board Independent Investigation Concludes Allegations Unsubstantiated (GlobeNewswire)
May-09-25 12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks) -6.67%
May-08-25 09:00PM	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:30PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:29PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	PacBio Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 12:38PM	Pacific Biosciences of California Q1 2025 Earnings Preview (Seeking Alpha)
11:08AM	Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result (GuruFocus.com)
May-05-25 09:05AM	First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand (GlobeNewswire)
Apr-29-25 06:15PM	Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-28-25 09:05AM	PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry (GlobeNewswire)
09:01AM	1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
06:15PM	Loading…
Apr-23-25 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know (Zacks)
Apr-22-25 09:05AM	Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa (GlobeNewswire)
Apr-09-25 02:38PM	PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know (StockStory) +20.83%
09:05AM	PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million (GlobeNewswire)
Apr-04-25 07:45PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +7.32%
Mar-27-25 09:05AM	Jim Gibson to join PacBio as Chief Financial Officer (GlobeNewswire)
Mar-20-25 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
01:05PM	Here's Why You Should Retain PacBio Stock in Your Portfolio Now (Zacks)
Mar-18-25 06:15PM	Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? (Insider Monkey)
05:08AM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
Mar-17-25 09:05AM	Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes (GlobeNewswire)
05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-14-25 06:15PM	Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Mar-11-25 09:01AM	1 Healthcare Stock to Target This Week and 2 to Turn Down (StockStory) -5.76%
Feb-19-25 04:05PM	PacBio to Participate in TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -5.35% -7.34%
Feb-15-25 11:02AM	PacBio should return to growth over time, says Canaccord (TipRanks)
Feb-14-25 11:09PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +25.00%
02:21AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Feb-13-25 06:00PM	Compared to Estimates, Pacific Biosciences (PACB) Q4 Earnings: A Look at Key Metrics (Zacks) +8.82%
05:20PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:13PM	PacBio (NASDAQ:PACB) Misses Q4 Sales Targets (StockStory)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire)
Feb-12-25 08:03AM	PacBio (PACB) Q4 Earnings Report Preview: What To Look For (StockStory)
07:42AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-04-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why (Zacks) +13.89%
Feb-03-25 09:05AM	PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service (GlobeNewswire) -5.19%
Jan-30-25 04:05PM	PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 (GlobeNewswire)
09:05AM	PacBio Announces Appointment of Chris Smith to Board of Directors (GlobeNewswire)
Jan-29-25 09:05AM	PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics (GlobeNewswire)
Jan-27-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know (Zacks)
Jan-24-25 09:16AM	PacBio announces GIFS at USask as first Revio PacBio CSP in Canada (TipRanks)
Jan-23-25 09:05AM	PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider (GlobeNewswire) -8.84%
Jan-14-25 09:05AM	PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics (GlobeNewswire) -7.96%
09:00AM	PacBio Announces Preliminary Fourth Quarter and Full Year Revenue (GlobeNewswire)
Jan-10-25 06:05AM	PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing (GlobeNewswire)
Jan-08-25 09:05AM	PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets (GlobeNewswire)
Jan-07-25 06:15PM	Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today (Zacks)
11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-02-25 04:05PM	PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.56%
Dec-30-24 03:03PM	Why Is Pacific Biosciences of California, Inc. (PACB) Among the Top CRISPR Stocks to Invest In? (Insider Monkey)
Dec-11-24 11:50AM	Why Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey)
Nov-19-24 07:01PM	Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey) +9.55%
Nov-12-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) -10.37%
Nov-08-24 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.12% +6.96%
06:03AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-07-24 07:30PM	Pacific Biosciences (PACB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -7.55%
06:15PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
05:14PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Third Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 (GlobeNewswire)
Nov-06-24 10:35PM	PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop (GlobeNewswire)
07:30AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-24 09:16AM	Curious about Pacific Biosciences (PACB) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Oct-31-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks) +12.44%
Oct-30-24 02:57PM	Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology (Insider Monkey)
10:13AM	Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep (PR Newswire)
Oct-29-24 09:05AM	PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500 (GlobeNewswire) +11.96%
Oct-22-24 09:05AM	PacBio Onso Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program (GlobeNewswire)
Oct-16-24 06:15PM	Pacific Biosciences of California (PACB) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks) -7.77%
Oct-11-24 09:05AM	PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing (GlobeNewswire) +27.74%
Oct-10-24 04:05PM	PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-01-24 09:05AM	PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore (GlobeNewswire)
Sep-27-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
04:05PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire)
Sep-13-24 06:15PM	Pacific Biosciences of California (PACB) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Sep-11-24 12:38PM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
09:05AM	PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific (GlobeNewswire)
Sep-08-24 04:51PM	Pacific Biosciences of California, Inc. (PACB): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM
Van Oene Mark	See Remarks	Jan 10 '25	Sale	2.03	34,405	69,980	1,597,454	Jan 10 04:54 PM
MARK VAN OENE	Officer	Jan 10 '25	Proposed Sale	2.03	34,405	69,980		Jan 10 04:23 PM
Kim Susan G.	See Remarks	Sep 30 '24	Sale	1.72	19,782	34,065	695,654	Oct 02 04:13 PM
SUSAN KIM	Officer	Sep 30 '24	Proposed Sale	1.72	19,782	34,061		Sep 30 04:03 PM
HENRY CHRISTIAN O	See Remarks	Sep 16 '24	Sale	1.75	98,907	172,692	2,497,763	Sep 17 04:11 PM
CHRISTIAN HENRY	Officer	Sep 16 '24	Proposed Sale	1.75	98,907	172,741		Sep 16 05:40 PM
Eidel Jeff	See Remarks	Aug 19 '24	Sale	1.59	26,760	42,602	869,730	Aug 20 05:27 PM
Van Oene Mark	See Remarks	Aug 16 '24	Sale	1.66	38,011	63,174	1,630,815	Aug 20 05:25 PM
JEFFREY EIDEL	Officer	Aug 19 '24	Proposed Sale	1.59	26,760	42,589		Aug 19 04:24 PM
MARK VAN OENE	Officer	Aug 16 '24	Proposed Sale	1.66	38,011	63,189		Aug 16 04:29 PM

Dollar change +0.37
Percentage change 3.79	%

DNA Ginkgo Bioworks Holdings Inc daily Stock Chart

Peers: REGN SGMO EDIT CRSP NTLA TWST DNLI BEAM FATE CERS

| Held by: VTI IWM VXF IWN THNQ VTWO IBB SCHA PRFZ VAW

Index	RUT	P/E	-	EPS (ttm)	-8.99	Insider Own	31.28%	Shs Outstand	43.08M	Perf Week	1.50%
Market Cap	592.93M	Forward P/E	-	EPS next Y	-4.86	Insider Trans	-0.03%	Shs Float	38.16M	Perf Month	18.48%
Enterprise Value	502.62M	PEG	-	EPS next Q	-1.57	Inst Own	56.98%	Short Float	31.50%	Perf Quarter	25.22%
Income	-472.07M	P/S	2.50	EPS this Y	41.87%	Inst Trans	-0.71%	Short Ratio	9.51	Perf Half Y	8.92%
Sales	237.42M	P/B	0.81	EPS next Y	20.73%	ROA	-32.84%	Short Interest	12.02M	Perf YTD	3.16%
Book/sh	12.52	P/C	1.13	EPS next 5Y	-	ROE	-57.76%	52W High	16.85 -39.88%	Perf Year	-27.64%
Cash/sh	8.97	P/FCF	-	EPS past 3/5Y	39.19% -27.97%	ROIC	-43.63%	52W Low	5.00 102.60%	Perf 3Y	-92.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-10.23% 31.19%	Gross Margin	54.42%	Volatility	6.99% 8.50%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.12	EPS Y/Y TTM	48.34%	Oper. Margin	-164.14%	ATR (14)	0.81	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.88	Sales Y/Y TTM	13.76%	Profit Margin	-198.84%	RSI (14)	53.07	Recom	3.75
Dividend Gr. 3/5Y	- -	Current Ratio	4.88	EPS Q/Q	49.35%	SMA20	-1.58%	Beta	1.49	Target Price	8.67
Payout	-	Debt/Eq	0.67	Sales Q/Q	27.34%	SMA50	14.56%	Rel Volume	1.23	Prev Close	9.76
Employees	834	LT Debt/Eq	0.67	Earnings	May 06 AMC	SMA200	13.30%	Avg Volume	1.26M	Price	10.13
IPO	Apr 19, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.55% 24.55%	Trades		Volume	1,551,050	Change	3.79%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform	$3.50 → $2.50
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell	$3 → $1.25
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy	$6
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight	$5
May-18-22	Downgrade	BofA Securities	Neutral → Underperform	$3
Mar-02-22	Resumed	Cowen	Outperform	$12
Feb-23-22	Initiated	Goldman	Neutral	$7
Feb-01-22	Initiated	BofA Securities	Neutral	$6
Jan-28-22	Initiated	BofA Securities	Buy	$8
Jan-07-22	Initiated	BTIG Research	Buy	$12
Nov-29-21	Initiated	Jefferies	Buy	$16
Oct-13-21	Initiated	Raymond James	Outperform	$14.50
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy	$14

Show Previous Ratings

Jul-17-25 09:01AM	Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors (PR Newswire)
Jul-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-10-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why (Zacks) -7.51%
Jul-01-25 06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
Jun-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know (Zacks)
04:05PM	Loading…
May-21-25 04:05PM	Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer (PR Newswire) -7.38% -7.43%
May-08-25 11:36PM	Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.35%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 06:30PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.79% +14.73%
05:00PM	Ginkgo Bioworks Reports First Quarter 2025 Financial Results (PR Newswire)
May-01-25 07:50AM	Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.56%
Apr-30-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
09:00AM	Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors (PR Newswire)
Apr-29-25 04:00PM	Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation (PR Newswire) -7.98%
Apr-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
09:00AM	Loading…
Apr-22-25 09:00AM	Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
09:00AM	Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
Apr-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know (Zacks)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +11.23%
Apr-10-25 09:55AM	Wall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a Bet (Zacks) +7.67%
09:00AM	Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain (PR Newswire)
Apr-01-25 10:26AM	Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
09:35AM	Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks (Zacks)
Mar-27-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) -7.13%
Mar-21-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +5.91%
Mar-14-25 09:35AM	After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) +7.89%
Mar-05-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why (Zacks)
Feb-25-25 05:00PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -11.47%
Feb-21-25 09:00AM	Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab (PR Newswire) -5.34%
Feb-20-25 08:01AM	Ginkgo Bioworks Partners with HaDEA in Up to 24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care (PR Newswire) -9.86%
08:00AM	Loading…
Feb-18-25 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation (PR Newswire) -6.52%
Feb-06-25 08:01AM	Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series (PR Newswire) -16.38%
Jan-29-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jan-23-25 08:01AM	Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) (PR Newswire)
Jan-13-25 08:01AM	Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors (PR Newswire) -9.41%
Jan-09-25 11:38AM	Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics (GlobeNewswire)
08:00AM	Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-17-24 12:00PM	All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy (Zacks)
08:11AM	Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program (PR Newswire)
Nov-12-24 05:01PM	Ginkgo Bioworks Reports Third Quarter 2024 Financial Results (PR Newswire)
08:01AM	Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing (PR Newswire)
Nov-05-24 07:00AM	Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation (PR Newswire)
Sep-24-24 07:01AM	NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture (PR Newswire)
Sep-18-24 07:01AM	Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology (PR Newswire) +8.81%
Sep-17-24 08:01AM	Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology (PR Newswire) +9.31%
Sep-04-24 04:30PM	Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement (PR Newswire)
Aug-30-24 07:00AM	Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) -5.64%
Aug-19-24 07:56AM	Upcoming Stock Splits This Week (August 19 to August 23) Stay Invested (TipRanks) +5.64%
Aug-08-24 05:01PM	Ginkgo Bioworks Reports Second Quarter 2024 Financial Results (PR Newswire) -5.46%
04:00PM	Global Agriculture Biologicals Testing Market Size To Worth USD 5.61 Billion by 2033 CAGR of 7.20% (GlobeNewswire)
Aug-02-24 07:00AM	Ginkgo Bioworks to Hold Special Meeting of Shareholders (PR Newswire) -14.97%
Aug-01-24 07:01AM	Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Presentation (PR Newswire)
Jul-16-24 07:01AM	Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals (Business Wire) +20.65%
Jul-11-24 06:00AM	3 Stocks to Avoid Like the Plague in 2024 (InvestorPlace)
Jul-10-24 04:08PM	3 High-Risk, Sky-High Reward Stocks to Buy for Under $1 (InvestorPlace) +5.35%
06:35AM	Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted (InvestorPlace)
Jul-08-24 07:00AM	7 F-Rated Stocks To Sell in July (InvestorPlace)
Jul-05-24 07:30AM	3 Biotech Stocks to Sell in July Before They Crash & Burn (InvestorPlace) -11.19%
Jun-27-24 03:38PM	Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich (InvestorPlace) +8.91%
Jun-26-24 12:48PM	Perion Layoffs 2024: What to Know About the Latest PERI Job Cuts (InvestorPlace) -11.31%
12:29PM	Ginkgo Bioworks Layoffs Expand to 400 Job Cuts (InvestorPlace)
Jun-24-24 10:52AM	Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears (InvestorPlace) -13.71%
10:31AM	Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts (InvestorPlace)
Jun-20-24 12:31PM	5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains (InvestorPlace)
Jun-19-24 12:00PM	7 Penny Stocks to Sell in June Before They Crash & Burn (InvestorPlace)
Jun-07-24 09:35AM	After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) -6.53%
May-31-24 07:00AM	3 Sorry Biotech Stocks to Sell in May While You Still Can (InvestorPlace) -5.51%
May-17-24 01:58PM	Hedge Fund and Insider Trading News: Paul Marshall, Ray Dalio, Boaz Weinstein, Bill Ackman, Stanley Druckenmiller, Eisler Capital, Archegos Capital Management, Ginkgo Bioworks Holdings Inc (DNA), Visa Inc (VISA), and More (Insider Monkey)
May-15-24 07:01AM	Ginkgo Bioworks to Participate in Two Conferences in May (PR Newswire)
May-14-24 06:00PM	Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan (PR Newswire)
May-13-24 04:05PM	Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE (PR Newswire) +10.49%
May-10-24 07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -17.29%
May-09-24 05:45PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Ginkgo Bioworks Reports First Quarter 2024 Financial Results (PR Newswire)
May-08-24 01:46PM	3 Meme Stocks to Sell in May Before They Crash & Burn (InvestorPlace)
May-07-24 12:31PM	Want $10,000? Invest $1,000 in These 3 Penny Stocks Now (InvestorPlace) -5.48%
11:43AM	16 Best US Stocks To Invest In Under $10 (Insider Monkey)
07:01AM	GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener (PR Newswire)
May-06-24 07:01AM	Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting (PR Newswire)
May-02-24 07:00AM	Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation (PR Newswire)
Apr-29-24 05:24PM	Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock? (InvestorPlace) +15.08% -9.97%
04:01PM	Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors (PR Newswire)
Apr-25-24 08:01AM	AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029 (PR Newswire) -8.05%
Apr-16-24 07:02AM	Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products (PR Newswire)
Apr-11-24 07:01AM	Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces 'Lab Data as a Service' (PR Newswire) -6.25%
07:01AM	Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets (PR Newswire)
Apr-10-24 07:02AM	Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain (PR Newswire)
07:01AM	Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks (PR Newswire)
Apr-08-24 07:00AM	IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service (PR Newswire)
Apr-04-24 07:01AM	Ginkgo Bioworks to Host 5th Annual Ferment Conference (PR Newswire)
Apr-03-24 07:02AM	Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing (PR Newswire)
Apr-02-24 07:02AM	Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs (PR Newswire) -6.25%
Mar-28-24 07:02AM	Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments (PR Newswire) +5.45%
Mar-27-24 07:02AM	AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production (PR Newswire)
Mar-26-24 07:02AM	Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins (PR Newswire)
Mar-13-24 05:04AM	ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network (PR Newswire)
Mar-12-24 07:01AM	CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago (PR Newswire)
Feb-29-24 05:01PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire) -15.13%
Feb-28-24 07:12AM	bit.bio Announced as Inaugural Partner of Ginkgo Bioworks New Technology Network (Business Wire)
07:03AM	Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions (PR Newswire)

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dmytruk Mark E.	Officer	Jul 17 '25	Proposed Sale	9.84	640	6,299		Jul 17 05:20 PM
Che Austin	Officer	Jul 09 '25	Proposed Sale	11.18	2,200	24,596		Jul 09 12:07 PM
Che Austin	Officer	Jun 23 '25	Proposed Sale	8.43	99	835		Jun 23 09:54 AM
Che Austin	Officer	Jun 20 '25	Proposed Sale	8.66	99	857		Jun 20 09:50 AM
Che Austin	Officer	Jun 18 '25	Proposed Sale	8.46	99	838		Jun 18 09:41 AM
Che Austin	Officer	Jun 17 '25	Proposed Sale	9.06	99	897		Jun 17 11:58 AM
Che Austin	Officer	Jun 16 '25	Proposed Sale	9.04	99	895		Jun 16 10:21 AM
Che Austin	Officer	Jun 13 '25	Proposed Sale	8.92	99	883		Jun 13 10:04 AM
Che Austin	Officer	Jun 12 '25	Proposed Sale	9.51	99	941		Jun 12 09:45 AM
Che Austin	Officer	Jun 11 '25	Proposed Sale	8.93	99	884		Jun 11 09:58 AM
Che Austin	Officer	Jun 10 '25	Proposed Sale	7.99	99	791		Jun 10 10:07 AM
Che Austin	Officer	Jun 09 '25	Proposed Sale	7.75	99	767		Jun 09 10:01 AM
Che Austin	Officer	Jun 06 '25	Proposed Sale	7.32	99	725		Jun 06 10:05 AM
Che Austin	Officer	Jun 05 '25	Proposed Sale	7.60	99	752		Jun 05 10:20 AM
Che Austin	Officer	Jun 04 '25	Proposed Sale	7.55	99	747		Jun 04 10:26 AM
Che Austin	Officer	Jun 03 '25	Proposed Sale	7.27	99	720		Jun 03 10:08 AM
Che Austin	Officer	Jun 02 '25	Proposed Sale	6.97	99	690		Jun 02 09:47 AM
Che Austin	Officer	May 30 '25	Proposed Sale	7.12	99	705		May 30 09:40 AM
Che Austin	Officer	May 29 '25	Proposed Sale	7.62	99	754		May 29 09:37 AM
Che Austin	Officer	May 28 '25	Proposed Sale	6.96	99	689		May 28 09:36 AM
Che Austin	Officer	May 27 '25	Proposed Sale	7.20	99	713		May 27 11:00 AM
Che Austin	Officer	May 23 '25	Proposed Sale	6.75	99	668		May 23 09:55 AM
Coen Steven P.	See remarks	May 21 '25	Sale	7.58	346	2,624	9,216	May 22 04:06 PM
Dmytruk Mark E.	See remarks	May 21 '25	Sale	7.58	706	5,355	46,226	May 22 04:05 PM
Che Austin	Officer	May 22 '25	Proposed Sale	7.15	99	708		May 22 09:54 AM
Dmytruk Mark E.	Officer	May 21 '25	Proposed Sale	7.58	706	5,355		May 21 04:11 PM
Che Austin	Officer	May 21 '25	Proposed Sale	7.86	99	778		May 21 09:54 AM
Che Austin	Officer	May 20 '25	Proposed Sale	8.10	99	802		May 20 09:41 AM
Che Austin	Officer	May 19 '25	Proposed Sale	7.70	99	762		May 19 11:03 AM
Che Austin	Officer	May 16 '25	Proposed Sale	7.72	99	764		May 16 09:40 AM
Che Austin	Officer	May 15 '25	Proposed Sale	7.73	99	765		May 15 10:57 AM
Che Austin	Officer	May 14 '25	Proposed Sale	8.01	99	793		May 14 10:18 AM
Che Austin	Officer	May 13 '25	Proposed Sale	8.40	99	832		May 13 09:48 AM
Che Austin	Officer	May 12 '25	Proposed Sale	8.16	99	808		May 12 09:44 AM
Che Austin	Officer	May 09 '25	Proposed Sale	7.97	99	789		May 09 09:40 AM
Che Austin	Officer	May 08 '25	Proposed Sale	7.49	99	742		May 08 09:46 AM
Che Austin	Officer	May 07 '25	Proposed Sale	6.83	99	676		May 07 09:52 AM
Che Austin	Officer	May 06 '25	Proposed Sale	6.75	99	668		May 06 09:41 AM
Che Austin	Officer	May 05 '25	Proposed Sale	7.00	99	693		May 05 09:58 AM
Che Austin	Officer	May 02 '25	Proposed Sale	7.15	99	708		May 02 09:41 AM
Che Austin	Officer	May 01 '25	Proposed Sale	7.47	99	740		May 01 10:07 AM
Che Austin	Officer	Apr 30 '25	Proposed Sale	7.14	99	707		Apr 30 09:59 AM
Che Austin	Officer	Apr 29 '25	Proposed Sale	7.94	99	786		Apr 29 09:51 AM
Che Austin	Officer	Apr 28 '25	Proposed Sale	7.95	99	787		Apr 28 09:50 AM
Che Austin	Officer	Apr 25 '25	Proposed Sale	7.92	99	784		Apr 25 09:49 AM
Che Austin	Officer	Apr 24 '25	Proposed Sale	7.68	99	760		Apr 24 09:47 AM
Coen Steven P.	See remarks	Apr 21 '25	Sale	7.28	997	7,261	8,819	Apr 23 05:03 PM
Dmytruk Mark E.	See remarks	Apr 21 '25	Sale	7.28	1,244	9,060	45,453	Apr 23 05:00 PM
Che Austin	Officer	Apr 23 '25	Proposed Sale	8.05	99	797		Apr 23 09:54 AM
Che Austin	Officer	Apr 22 '25	Proposed Sale	7.49	99	742		Apr 22 09:48 AM
Dmytruk Mark E.	Officer	Apr 21 '25	Proposed Sale	7.28	1,244	9,060		Apr 21 04:16 PM
Che Austin	Officer	Apr 21 '25	Proposed Sale	7.50	99	742		Apr 21 09:51 AM
Che Austin	Officer	Apr 17 '25	Proposed Sale	8.09	99	801		Apr 17 09:49 AM
Che Austin	Officer	Apr 16 '25	Proposed Sale	8.17	99	809		Apr 16 09:49 AM
Che Austin	Officer	Apr 15 '25	Proposed Sale	8.41	99	833		Apr 15 09:47 AM
Che Austin	Officer	Apr 14 '25	Proposed Sale	8.37	99	829		Apr 14 10:10 AM
Che Austin	Officer	Apr 11 '25	Proposed Sale	7.50	99	742		Apr 11 09:42 AM
Che Austin	Officer	Apr 10 '25	Proposed Sale	6.54	99	647		Apr 10 09:45 AM
Che Austin	Officer	Apr 09 '25	Proposed Sale	5.73	99	567		Apr 09 09:47 AM
Che Austin	Officer	Apr 08 '25	Proposed Sale	6.80	99	673		Apr 08 09:38 AM
Che Austin	Officer	Apr 07 '25	Proposed Sale	5.16	99	511		Apr 07 10:36 AM
Che Austin	Officer	Apr 04 '25	Proposed Sale	5.50	99	544		Apr 04 09:40 AM
Che Austin	Officer	Apr 03 '25	Proposed Sale	5.50	99	544		Apr 03 10:17 AM
Che Austin	Officer	Apr 02 '25	Proposed Sale	5.45	99	540		Apr 02 10:10 AM
Che Austin	Officer	Apr 01 '25	Proposed Sale	5.69	99	563		Apr 01 10:57 AM
Che Austin	Officer	Mar 31 '25	Proposed Sale	5.73	99	567		Mar 31 09:58 AM
Che Austin	Officer	Mar 28 '25	Proposed Sale	6.54	99	647		Mar 28 10:57 AM
Che Austin	Officer	Mar 27 '25	Proposed Sale	6.63	99	656		Mar 27 09:36 AM
Che Austin	Officer	Mar 26 '25	Proposed Sale	7.11	99	704		Mar 26 09:49 AM
Che Austin	Officer	Mar 25 '25	Proposed Sale	7.75	99	767		Mar 25 09:51 AM
Che Austin	Officer	Mar 24 '25	Proposed Sale	7.53	99	745		Mar 24 09:53 AM
Che Austin	Officer	Mar 21 '25	Proposed Sale	7.00	99	693		Mar 21 09:44 AM
Che Austin	Officer	Mar 20 '25	Proposed Sale	7.40	99	733		Mar 20 09:42 AM
Che Austin	Officer	Mar 19 '25	Proposed Sale	7.27	99	720		Mar 19 09:42 AM
Che Austin	Officer	Mar 18 '25	Proposed Sale	7.88	99	780		Mar 18 09:51 AM
Che Austin	Officer	Mar 17 '25	Proposed Sale	7.02	99	695		Mar 17 10:22 AM
Che Austin	Officer	Mar 14 '25	Proposed Sale	6.76	99	669		Mar 14 09:40 AM
Che Austin	Officer	Mar 13 '25	Proposed Sale	6.77	99	670		Mar 13 09:46 AM
Che Austin	Officer	Mar 12 '25	Proposed Sale	7.21	99	714		Mar 12 09:47 AM
Che Austin	Officer	Mar 11 '25	Proposed Sale	6.98	99	691		Mar 11 12:03 PM
Che Austin	Officer	Mar 10 '25	Proposed Sale	7.32	99	725		Mar 10 09:46 AM
Che Austin	Officer	Mar 07 '25	Proposed Sale	7.75	99	767		Mar 07 09:43 AM
Coen Steven P.	See remarks	Mar 04 '25	Sale	7.72	395	3,051	8,012	Mar 06 05:06 PM
Dmytruk Mark E.	See remarks	Mar 04 '25	Sale	7.72	790	6,103	34,652	Mar 06 05:00 PM
Che Austin	Officer	Mar 06 '25	Proposed Sale	7.97	99	789		Mar 06 12:03 PM
Che Austin	Officer	Mar 05 '25	Proposed Sale	8.33	99	825		Mar 05 09:50 AM
Dmytruk Mark E.	Officer	Mar 04 '25	Proposed Sale	7.73	790	6,103		Mar 04 03:34 PM
Che Austin	Officer	Mar 04 '25	Proposed Sale	7.75	99	767		Mar 04 10:01 AM
Che Austin	Officer	Mar 03 '25	Proposed Sale	8.45	99	837		Mar 03 11:00 AM
Che Austin	Officer	Feb 28 '25	Proposed Sale	8.37	99	829		Feb 28 09:36 AM
Che Austin	Officer	Feb 27 '25	Proposed Sale	9.26	99	917		Feb 27 10:14 AM
Che Austin	Officer	Feb 26 '25	Proposed Sale	9.00	99	891		Feb 26 09:47 AM
Che Austin	Officer	Feb 25 '25	Proposed Sale	10.40	99	1,030		Feb 25 11:38 AM
Che Austin	Officer	Feb 24 '25	Proposed Sale	10.75	99	1,064		Feb 24 09:57 AM
Che Austin	Officer	Feb 21 '25	Proposed Sale	11.70	99	1,158		Feb 21 09:47 AM
Che Austin	Officer	Feb 20 '25	Proposed Sale	12.50	99	1,238		Feb 20 11:00 AM
Che Austin	Officer	Feb 19 '25	Proposed Sale	13.58	99	1,344		Feb 19 09:49 AM
Che Austin	Officer	Feb 18 '25	Proposed Sale	15.29	99	1,514		Feb 18 11:28 AM
Che Austin	Officer	Feb 14 '25	Proposed Sale	14.00	99	1,386		Feb 14 09:50 AM
Che Austin	Officer	Feb 13 '25	Proposed Sale	12.68	99	1,255		Feb 13 09:46 AM

PACB

Pacific Biosciences of California Inc

DNA

Ginkgo Bioworks Holdings Inc

Upgrade your FINVIZ experience